Gene · 9294
Papers2,171
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,171
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis. | Biomedicines | 2024 | 38255213 | PubTator, text mining | PubMed |
| Investigation of the Potential Mechanism of Compound Dragon's Blood Capsule against Myocardial Ischemia Based on Network Pharmacology. | Comb Chem High Throughput Screen | 2024 | 38231051 | PubTator, text mining | PubMed |
| S1PR2: A Fulcrum in the Balance of Type 1 and Type 2 Responses during Sepsis-induced Acute Lung Injury. | Am J Respir Cell Mol Biol | 2024 | 38226863 | PubTator, text mining | PubMed |
| Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). | Respir Res | 2024 | 38218783 | PubTator, text mining | PubMed |
| Dynamics of self-hybridized exciton-polaritons in 2D halide perovskites. | Light Sci Appl | 2024 | 38161209 | PubTator, text mining | PubMed |
| Bile acids regulate SF-1 to alter cholesterol balance in adrenocortical cells via S1PR2. | Biochem Biophys Res Commun | 2024 | 38061283 | PubTator, text mining | PubMed |
| Lack of S1PR2 in Macrophage Ameliorates Sepsis-associated Lung Injury through Inducing IL-33-mediated Type 2 Immunity. | Am J Respir Cell Mol Biol | 2024 | 38061028 | PubTator, text mining | PubMed |
| Necessary Role of Ceramides in the Human Microvascular Endothelium During Health and Disease. | Circ Res | 2024 | 38037825 | PubTator, text mining | PubMed |
| Fingolimod (FTY720), an FDA-approved sphingosine 1-phosphate (S1P) receptor agonist, restores endothelial hyperpermeability in cellular and animal models of dengue virus serotype 2 infection. | IUBMB Life | 2024 | 38031996 | PubTator, text mining | PubMed |
| Targeting the SPHK1/S1P/S1PR2 axis ameliorates GH-secreted pituitary adenoma progression. | Eur J Clin Invest | 2024 | 37888843 | PubTator, text mining | PubMed |
| Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical Nerve-Terminals of Insulin-Resistant Goto-Kakizaki Rats and Diet-Induced Obese Mice. | Neurochem Res | 2024 | 37794263 | PubTator, text mining | PubMed |
| Activation of S1P2 is protective against cisplatin-induced peripheral neuropathy. | Cell Prolif | 2024 | 37727014 | PubTator, text mining | PubMed |
| Assessing the risk of prenatal depressive symptoms in Chinese women: an integrated evaluation of serum metabolome, multivitamin supplement intake, and clinical blood indicators. | Front Psychiatry | 2023 | 38274432 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Editorial: Sphingolipids in cardiovascular diseases: from pathogenesis to therapeutics. | Front Cardiovasc Med | 2023 | 38259309 | PubTator, text mining | PubMed |
| The contributions of bacteria metabolites to the development of hepatic encephalopathy. | Liver Res | 2023 | 38221945 | PubTator, text mining | PubMed |
| The Role of TAM Receptors in Bone. | Int J Mol Sci | 2023 | 38203403 | PubTator, text mining | PubMed |
| Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy. | Int J Mol Sci | 2023 | 38203175 | PubTator, text mining | PubMed |
| The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease. | Front Cell Neurosci | 2023 | 38179204 | PubTator, text mining | PubMed |
| The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance. | Front Pharmacol | 2023 | 38161698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9294/papers?page=7